This study is looking at how certain things in the blood might help doctors predict how well people with Parkinson's disease will respond to a surgery called Deep Brain Stimulation (DBS). Parkinson’s disease is a brain disorder that affects movement. DBS is a treatment that helps control symptoms by sending electrical signals to the brain.
Researchers will take blood samples and some leftover brain tissue from the surgery to find proteins and RNA (a molecule similar to DNA) that could be linked to how well DBS works. This study will not change the surgery itself.
- Participation: Participants must have Parkinson's and be eligible for DBS according to guidelines.
- Compensation and Visits: Study details on compensation or visits are not mentioned.
- Risks: There are no additional risks from the study beyond the typical surgery risks.
This study could help doctors better predict and improve outcomes for Parkinson's patients undergoing DBS.